Showing results (71-80 of 185) with videos related to

Sort By:
Pageof 19
Clinical Breast Cancer|November 5, 2024
Clinicopathologic Features and Digital Imaging Analysis of HER2 Protein in Breast Carcinomas With Different HER2 Fluorescence in Situ Hybridization PatternsAidan C Li, Scott Hammond, Debra Crosby, et al.
Human Pathology|November 6, 2020
ESR1 genetic alterations and their association with clinicopathologic characteristics in advanced breast cancer: a single academic institution experienceC Eric Freitag, Ping Mei, Lai Wei, et al.
Human Pathology|May 24, 2020
Genetic alterations and their association with clinicopathologic characteristics in advanced breast carcinomas: focusing on clinically actionable genetic alterationsCody Eric Freitag, Ping Mei, Lai Wei, et al.
Cancer Cytopathology|April 27, 2019
Programmed cell death ligand 1 expression in cytologic and surgical non-small cell lung carcinoma specimens from a single institution: Association with clinicopathologic features and molecular alterationsPing Mei, Konstantin Shilo, Lai Wei, et al.
Journal of the American Society of Cytopathology|May 18, 2019
The reporting rates of atypical glandular cells and their HPV testing and histologic follow-up results: a comparison between ThinPrep and SurePath preparations from a single academic institutionShiguang Liu, I-Sanna Gibbons-Fideler, Dena Tonkovich, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 15, 2019
Clinicopathologic characteristics, tumor infiltrating lymphocytes and programed cell death ligand-1 expression in 162 endometrial carcinomas with deficient mismatch repair functionJesus A Chavez, Lai Wei, Adrian A Suarez, et al.
Human Pathology|May 29, 2025
Artificial intelligence in breast pathology: Overview and recent updatesSneha Datwani, Hikmat Khan, Muhammad Khalid Khan Niazi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 24, 2025
Incidence, Clinicopathologic Features, and Follow-Up Results of human epidermal growth factor receptor-2-Ultralow Breast CarcinomaYan Hu, Daniel Jones, Weiqiang Zhao, et al.
Clinical Breast Cancer|February 8, 2022
Evaluating Mismatch Repair Status to Screen Clinical Advanced Breast Carcinomas for Immunotherapy: Experience From a Large Academic InstitutionVidya Arole, Saba Shafi, Bindu Challa, et al.
American Journal of Clinical Pathology|March 1, 2023
HER2 Gene Protein Assay: A Robust Tool for Evaluating HER2 Status and Intratumoral Heterogeneity in Endometrial CancersSaba Shafi, Hiroaki Nitta, Manan Shah, et al.
Pageof 19